MAKAYLA GREEN: Open Payments
NPI 1154952844 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,933 in 146 payments from 40 companies in 2025. Trend: 2023 $2,302 · 2024 $2,429 · 2025 $2,933
Food & beverage: $2,833Education: $100
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $310 |
| Janssen Biotech, Inc. | 13 | $268 |
| ABBVIE INC. | 12 | $242 |
| Astellas Pharma US Inc | 7 | $205 |
| Daiichi Sankyo Inc. | 9 | $161 |
| Regeneron Healthcare Solutions, Inc. | 7 | $160 |
| Novartis Pharmaceuticals Corporation | 8 | $143 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Celgene Corporation | 5 | $103 |
Products named: KEYTRUDA, LIBTAYO, VENCLEXTA, KISQALI, Enhertu, FRUZAQLA, TALVEY, FOTIVDA.
Industry payments across KY — which companies pay providers there.
